APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atazanavir

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Atazanavir Market Analysis and Forecast 2026-2032

20 December 2025197 pages

Choose your research edition.

Industry ResearchAtazanavir Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Atazanavir Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Atazanavir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atazanavir Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Atazanavir Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Atazanavir market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Atazanavir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Atazanavir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Atazanavir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Atazanavir is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Atazanavir include TEVA, Mylan, Emcure, Cipla, Bristol-Myers Squibb and Aurobindo Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Atazanavir, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Atazanavir, also provides the sales of main regions and countries. Of the upcoming market potential for Atazanavir, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Atazanavir sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Atazanavir market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Atazanavir sales, projected growth trends, production technology, application and end-user industry.

Atazanavir Segment by Company

TEVA

Mylan

Emcure

Cipla

Bristol-Myers Squibb

Aurobindo Pharma

Atazanavir Segment by Type

50 mg Oral Powder

300 mg Capsule

200 mg Capsule

150 mg Capsule

Atazanavir Segment by Application

Adults

Children 3 months of age and older

Atazanavir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atazanavir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atazanavir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atazanavir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Atazanavir in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Atazanavir manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atazanavir sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Atazanavir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50 mg Oral Powder Major Manufacturers Table 3. 300 mg Capsule Major Manufacturers Table 4. 200 mg Capsule Major Manufacturers Table 5. 150 mg Capsule Major Manufacturers Table 6. Global Atazanavir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Adults Major Manufacturers Table 8. Children 3 months of age and older Major Manufacturers Table 9. Atazanavir Industry Trends Table 10. Atazanavir Industry Drivers Table 11. Atazanavir Industry Opportunities and Challenges Table 12. Atazanavir Industry Restraints Table 13. Global Atazanavir Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Atazanavir Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Atazanavir Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Atazanavir Revenue Market Share by Region (2021-2026) Table 17. Global Atazanavir Revenue Market Share by Region (2027-2032) Table 18. Global Atazanavir Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 19. Global Atazanavir Sales by Region (2021-2026) & (W Units) Table 20. Global Atazanavir Sales by Region (2027-2032) & (W Units) Table 21. Global Atazanavir Sales Market Share by Region (2021-2026) Table 22. Global Atazanavir Sales Market Share by Region (2027-2032) Table 23. Global Atazanavir Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Atazanavir Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Atazanavir Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Atazanavir Sales Market Share by Manufacturers (2021-2026) Table 27. Global Atazanavir Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Atazanavir Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Atazanavir Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Atazanavir Manufacturers, Product Type & Application Table 31. Global Atazanavir Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Atazanavir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Atazanavir Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Atazanavir Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Atazanavir Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Atazanavir Revenue Market Share by Type (2021-2026) Table 38. Global Atazanavir Revenue Market Share by Type (2027-2032) Table 39. Global Atazanavir Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 40. Global Atazanavir Sales by Type (2021-2026) & (W Units) Table 41. Global Atazanavir Sales by Type (2027-2032) & (W Units) Table 42. Global Atazanavir Sales Market Share by Type (2021-2026) Table 43. Global Atazanavir Sales Market Share by Type (2027-2032) Table 44. Global Atazanavir Price by Type (2021-2026) & (US$/Unit) Table 45. Global Atazanavir Price by Type (2027-2032) & (US$/Unit) Table 46. Global Atazanavir Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Atazanavir Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Atazanavir Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Atazanavir Revenue Market Share by Application (2021-2026) Table 50. Global Atazanavir Revenue Market Share by Application (2027-2032) Table 51. Global Atazanavir Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 52. Global Atazanavir Sales by Application (2021-2026) & (W Units) Table 53. Global Atazanavir Sales by Application (2027-2032) & (W Units) Table 54. Global Atazanavir Sales Market Share by Application (2021-2026) Table 55. Global Atazanavir Sales Market Share by Application (2027-2032) Table 56. Global Atazanavir Price by Application (2021-2026) & (US$/Unit) Table 57. Global Atazanavir Price by Application (2027-2032) & (US$/Unit) Table 58. TEVA Company Information Table 59. TEVA Business Overview Table 60. TEVA Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. TEVA Atazanavir Product Portfolio Table 62. TEVA Recent Development Table 63. Mylan Company Information Table 64. Mylan Business Overview Table 65. Mylan Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Mylan Atazanavir Product Portfolio Table 67. Mylan Recent Development Table 68. Emcure Company Information Table 69. Emcure Business Overview Table 70. Emcure Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Emcure Atazanavir Product Portfolio Table 72. Emcure Recent Development Table 73. Cipla Company Information Table 74. Cipla Business Overview Table 75. Cipla Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Cipla Atazanavir Product Portfolio Table 77. Cipla Recent Development Table 78. Bristol-Myers Squibb Company Information Table 79. Bristol-Myers Squibb Business Overview Table 80. Bristol-Myers Squibb Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Bristol-Myers Squibb Atazanavir Product Portfolio Table 82. Bristol-Myers Squibb Recent Development Table 83. Aurobindo Pharma Company Information Table 84. Aurobindo Pharma Business Overview Table 85. Aurobindo Pharma Atazanavir Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Aurobindo Pharma Atazanavir Product Portfolio Table 87. Aurobindo Pharma Recent Development Table 88. North America Atazanavir Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Atazanavir Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Atazanavir Sales by Type (2021-2026) & (W Units) Table 91. North America Atazanavir Sales by Type (2027-2032) & (W Units) Table 92. North America Atazanavir Sales Price by Type (2021-2026) & (US$/Unit) Table 93. North America Atazanavir Sales Price by Type (2027-2032) & (US$/Unit) Table 94. North America Atazanavir Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Atazanavir Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Atazanavir Sales by Application (2021-2026) & (W Units) Table 97. North America Atazanavir Sales by Application (2027-2032) & (W Units) Table 98. North America Atazanavir Sales Price by Application (2021-2026) & (US$/Unit) Table 99. North America Atazanavir Sales Price by Application (2027-2032) & (US$/Unit) Table 100. North America Atazanavir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Atazanavir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 102. North America Atazanavir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 103. North America Atazanavir Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 104. North America Atazanavir Sales by Country (2021-2026) & (W Units) Table 105. North America Atazanavir Sales by Country (2027-2032) & (W Units) Table 106. North America Atazanavir Sales Price by Country (2021-2026) & (US$/Unit) Table 107. North America Atazanavir Sales Price by Country (2027-2032) & (US$/Unit) Table 108. United States Atazanavir Revenue (2021-2032) & (US$ Million) Table 109. Canada Atazanavir Revenue (2021-2032) & (US$ Million) Table 110. Europe Atazanavir Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Atazanavir Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Atazanavir Sales by Type (2021-2026) & (W Units) Table 113. Europe Atazanavir Sales by Type (2027-2032) & (W Units) Table 114. Europe Atazanavir Sales Price by Type (2021-2026) & (US$/Unit) Table 115. Europe Atazanavir Sales Price by Type (2027-2032) & (US$/Unit) Table 116. Europe Atazanavir Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Atazanavir Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Atazanavir Sales by Application (2021-2026) & (W Units) Table 119. Europe Atazanavir Sales by Application (2027-2032) & (W Units) Table 120. Europe Atazanavir Sales Price by Application (2021-2026) & (US$/Unit) Table 121. Europe Atazanavir Sales Price by Application (2027-2032) & (US$/Unit) Table 122. Europe Atazanavir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Atazanavir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Atazanavir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Atazanavir Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 126. Europe Atazanavir Sales by Country (2021-2026) & (W Units) Table 127. Europe Atazanavir Sales by Country (2027-2032) & (W Units) Table 128. Europe Atazanavir Sales Price by Country (2021-2026) & (US$/Unit) Table 129. Europe Atazanavir Sales Price by Country (2027-2032) & (US$/Unit) Table 130. Germany Atazanavir Revenue (2021-2032) & (US$ Million) Table 131. France Atazanavir Revenue (2021-2032) & (US$ Million) Table 132. U.K. Atazanavir Revenue (2021-2032) & (US$ Million) Table 133. Italy Atazanavir Revenue (2021-2032) & (US$ Million) Table 134. Netherlands Atazanavir Revenue (2021-2032) & (US$ Million) Table 135. China Atazanavir Revenue by Type (2021-2026) & (US$ Million) Table 136. China Atazanavir Revenue by Type (2027-2032) & (US$ Million) Table 137. China Atazanavir Sales by Type (2021-2026) & (W Units) Table 138. China Atazanavir Sales by Type (2027-2032) & (W Units) Table 139. China Atazanavir Sales Price by Type (2021-2026) & (US$/Unit) Table 140. China Atazanavir Sales Price by Type (2027-2032) & (US$/Unit) Table 141. China Atazanavir Revenue by Application (2021-2026) & (US$ Million) Table 142. China Atazanavir Revenue by Application (2027-2032) & (US$ Million) Table 143. China Atazanavir Sales by Application (2021-2026) & (W Units) Table 144. China Atazanavir Sales by Application (2027-2032) & (W Units) Table 145. China Atazanavir Sales Price by Application (2021-2026) & (US$/Unit) Table 146. China Atazanavir Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Asia Atazanavir Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Atazanavir Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Atazanavir Sales by Type (2021-2026) & (W Units) Table 150. Asia Atazanavir Sales by Type (2027-2032) & (W Units) Table 151. Asia Atazanavir Sales Price by Type (2021-2026) & (US$/Unit) Table 152. Asia Atazanavir Sales Price by Type (2027-2032) & (US$/Unit) Table 153. Asia Atazanavir Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Atazanavir Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Atazanavir Sales by Application (2021-2026) & (W Units) Table 156. Asia Atazanavir Sales by Application (2027-2032) & (W Units) Table 157. Asia Atazanavir Sales Price by Application (2021-2026) & (US$/Unit) Table 158. Asia Atazanavir Sales Price by Application (2027-2032) & (US$/Unit) Table 159. Asia Atazanavir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Atazanavir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Atazanavir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Atazanavir Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 163. Asia Atazanavir Sales by Country (2021-2026) & (W Units) Table 164. Asia Atazanavir Sales by Country (2027-2032) & (W Units) Table 165. Asia Atazanavir Sales Price by Country (2021-2026) & (US$/Unit) Table 166. Asia Atazanavir Sales Price by Country (2027-2032) & (US$/Unit) Table 167. Japan Atazanavir Revenue (2021-2032) & (US$ Million) Table 168. South Korea Atazanavir Revenue (2021-2032) & (US$ Million) Table 169. India Atazanavir Revenue (2021-2032) & (US$ Million) Table 170. Australia Atazanavir Revenue (2021-2032) & (US$ Million) Table 171. China Taiwan Atazanavir Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Atazanavir Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Atazanavir Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Atazanavir Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Atazanavir Sales by Type (2021-2026) & (W Units) Table 176. SAMEA Atazanavir Sales by Type (2027-2032) & (W Units) Table 177. SAMEA Atazanavir Sales Price by Type (2021-2026) & (US$/Unit) Table 178. SAMEA Atazanavir Sales Price by Type (2027-2032) & (US$/Unit) Table 179. SAMEA Atazanavir Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Atazanavir Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Atazanavir Sales by Application (2021-2026) & (W Units) Table 182. SAMEA Atazanavir Sales by Application (2027-2032) & (W Units) Table 183. SAMEA Atazanavir Sales Price by Application (2021-2026) & (US$/Unit) Table 184. SAMEA Atazanavir Sales Price by Application (2027-2032) & (US$/Unit) Table 185. SAMEA Atazanavir Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Atazanavir Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Atazanavir Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Atazanavir Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 189. SAMEA Atazanavir Sales by Country (2021-2026) & (W Units) Table 190. SAMEA Atazanavir Sales by Country (2027-2032) & (W Units) Table 191. SAMEA Atazanavir Sales Price by Country (2021-2026) & (US$/Unit) Table 192. SAMEA Atazanavir Sales Price by Country (2027-2032) & (US$/Unit) Table 193. Brazil Atazanavir Revenue (2021-2032) & (US$ Million) Table 194. Argentina Atazanavir Revenue (2021-2032) & (US$ Million) Table 195. Chile Atazanavir Revenue (2021-2032) & (US$ Million) Table 196. Colombia Atazanavir Revenue (2021-2032) & (US$ Million) Table 197. Peru Atazanavir Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Atazanavir Revenue (2021-2032) & (US$ Million) Table 199. Israel Atazanavir Revenue (2021-2032) & (US$ Million) Table 200. UAE Atazanavir Revenue (2021-2032) & (US$ Million) Table 201. Turkey Atazanavir Revenue (2021-2032) & (US$ Million) Table 202. Iran Atazanavir Revenue (2021-2032) & (US$ Million) Table 203. Egypt Atazanavir Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Atazanavir Distributors List Table 207. Atazanavir Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Atazanavir Image Figure 2. Global Atazanavir Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atazanavir Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50 mg Oral Powder Image Figure 5. 300 mg Capsule Image Figure 6. 200 mg Capsule Image Figure 7. 150 mg Capsule Image Figure 8. Global Atazanavir Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Atazanavir Market Size Share 2021 VS 2025 VS 2032 Figure 10. Adults Image Figure 11. Children 3 months of age and older Image Figure 12. Global Atazanavir Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Atazanavir Revenue (2021-2032) & (US$ Million) Figure 14. Global Atazanavir Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Atazanavir Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Atazanavir Revenue Market Share by Region (2021-2032) Figure 17. Global Atazanavir Sales (2021-2032) & (W Units) Figure 18. Global Atazanavir Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 19. Global Atazanavir Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Atazanavir Sales YoY (2021-2032) & (W Units) Figure 21. Europe Atazanavir Sales YoY (2021-2032) & (W Units) Figure 22. China Atazanavir Sales YoY (2021-2032) & (W Units) Figure 23. Asia (Excluding China) Atazanavir Sales YoY (2021-2032) & (W Units) Figure 24. South America, Middle East and Africa Atazanavir Sales YoY (2021-2032) & (W Units) Figure 25. Global Atazanavir Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Atazanavir Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Atazanavir Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Atazanavir Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Atazanavir Revenue Market Share by Type (2021-2032) Figure 31. Global Atazanavir Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 32. Global Atazanavir Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Atazanavir Sales Market Share by Type (2021-2032) Figure 34. Global Atazanavir Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Atazanavir Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Atazanavir Revenue Market Share by Application (2021-2032) Figure 37. Global Atazanavir Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 38. Global Atazanavir Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Atazanavir Sales Market Share by Application (2021-2032) Figure 40. North America Atazanavir Revenue Share by Type (2021-2032) Figure 41. North America Atazanavir Sales Share by Type (2021-2032) Figure 42. North America Atazanavir Revenue Share by Application (2021-2032) Figure 43. North America Atazanavir Sales Share by Application (2021-2032) Figure 44. North America Atazanavir Revenue Share by Country (2021-2032) Figure 45. North America Atazanavir Sales Share by Country (2021-2032) Figure 46. Europe Atazanavir Revenue Share by Type (2021-2032) Figure 47. Europe Atazanavir Sales Share by Type (2021-2032) Figure 48. Europe Atazanavir Revenue Share by Application (2021-2032) Figure 49. Europe Atazanavir Sales Share by Application (2021-2032) Figure 50. Europe Atazanavir Revenue Share by Country (2021-2032) Figure 51. Europe Atazanavir Sales Share by Country (2021-2032) Figure 52. China Atazanavir Revenue Share by Type (2021-2032) Figure 53. China Atazanavir Sales Share by Type (2021-2032) Figure 54. China Atazanavir Revenue Share by Application (2021-2032) Figure 55. China Atazanavir Sales Share by Application (2021-2032) Figure 56. Asia Atazanavir Revenue Share by Type (2021-2032) Figure 57. Asia Atazanavir Sales Share by Type (2021-2032) Figure 58. Asia Atazanavir Revenue Share by Application (2021-2032) Figure 59. Asia Atazanavir Sales Share by Application (2021-2032) Figure 60. Asia Atazanavir Revenue Share by Country (2021-2032) Figure 61. Asia Atazanavir Sales Share by Country (2021-2032) Figure 62. SAMEA Atazanavir Revenue Share by Type (2021-2032) Figure 63. SAMEA Atazanavir Sales Share by Type (2021-2032) Figure 64. SAMEA Atazanavir Revenue Share by Application (2021-2032) Figure 65. SAMEA Atazanavir Sales Share by Application (2021-2032) Figure 66. SAMEA Atazanavir Revenue Share by Country (2021-2032) Figure 67. SAMEA Atazanavir Sales Share by Country (2021-2032) Figure 68. Atazanavir Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Atazanavir Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 50 mg Oral Powder
  • 300 mg Capsule
  • 200 mg Capsule
  • 150 mg Capsule
Applications
  • Adults
  • Children 3 months of age and older
Companies covered
  • TEVA
  • Mylan
  • Emcure
  • Cipla
  • Bristol-Myers Squibb
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Atazanavir Market by Type
  3. 1.2.1 Global Atazanavir Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50 mg Oral Powder
  5. 1.2.3 300 mg Capsule
  6. 1.2.4 200 mg Capsule
  7. 1.2.5 150 mg Capsule
  8. 1.3 Atazanavir Market by Application
  9. 1.3.1 Global Atazanavir Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Adults
  11. 1.3.3 Children 3 months of age and older
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Atazanavir Market Dynamics
  1. 2.1 Atazanavir Industry Trends
  2. 2.2 Atazanavir Industry Drivers
  3. 2.3 Atazanavir Industry Opportunities and Challenges
  4. 2.4 Atazanavir Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Atazanavir Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Atazanavir Revenue by Region
  3. 3.2.1 Global Atazanavir Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Atazanavir Revenue by Region (2021-2026)
  5. 3.2.3 Global Atazanavir Revenue by Region (2027-2032)
  6. 3.2.4 Global Atazanavir Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Atazanavir Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Atazanavir Sales by Region
  9. 3.4.1 Global Atazanavir Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Atazanavir Sales by Region (2021-2026)
  11. 3.4.3 Global Atazanavir Sales by Region (2027-2032)
  12. 3.4.4 Global Atazanavir Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Atazanavir Revenue by Manufacturers
  2. 4.1.1 Global Atazanavir Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Atazanavir Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Atazanavir Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Atazanavir Sales by Manufacturers
  6. 4.2.1 Global Atazanavir Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Atazanavir Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Atazanavir Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Atazanavir Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Atazanavir Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Atazanavir Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Atazanavir Manufacturers, Product Type & Application
  13. 4.7 Global Atazanavir Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Atazanavir Market CR5 and HHI
  16. 4.8.2 2025 Atazanavir Tier 1, Tier 2, and Tier 3
5 Atazanavir Market by Type
  1. 5.1 Global Atazanavir Revenue by Type
  2. 5.1.1 Global Atazanavir Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Atazanavir Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Atazanavir Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Atazanavir Sales by Type
  6. 5.2.1 Global Atazanavir Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atazanavir Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Atazanavir Sales Market Share by Type (2021-2032)
  9. 5.3 Global Atazanavir Price by Type
6 Atazanavir Market by Application
  1. 6.1 Global Atazanavir Revenue by Application
  2. 6.1.1 Global Atazanavir Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Atazanavir Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Atazanavir Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Atazanavir Sales by Application
  6. 6.2.1 Global Atazanavir Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Atazanavir Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Atazanavir Sales Market Share by Application (2021-2032)
  9. 6.3 Global Atazanavir Price by Application
7 Company Profiles
  1. 7.1 TEVA
  2. 7.1.1 TEVA Company Information
  3. 7.1.2 TEVA Business Overview
  4. 7.1.3 TEVA Atazanavir Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 TEVA Atazanavir Product Portfolio
  6. 7.1.5 TEVA Recent Developments
  7. 7.2 Mylan
  8. 7.2.1 Mylan Company Information
  9. 7.2.2 Mylan Business Overview
  10. 7.2.3 Mylan Atazanavir Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mylan Atazanavir Product Portfolio
  12. 7.2.5 Mylan Recent Developments
  13. 7.3 Emcure
  14. 7.3.1 Emcure Company Information
  15. 7.3.2 Emcure Business Overview
  16. 7.3.3 Emcure Atazanavir Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Emcure Atazanavir Product Portfolio
  18. 7.3.5 Emcure Recent Developments
  19. 7.4 Cipla
  20. 7.4.1 Cipla Company Information
  21. 7.4.2 Cipla Business Overview
  22. 7.4.3 Cipla Atazanavir Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Cipla Atazanavir Product Portfolio
  24. 7.4.5 Cipla Recent Developments
  25. 7.5 Bristol-Myers Squibb
  26. 7.5.1 Bristol-Myers Squibb Company Information
  27. 7.5.2 Bristol-Myers Squibb Business Overview
  28. 7.5.3 Bristol-Myers Squibb Atazanavir Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Bristol-Myers Squibb Atazanavir Product Portfolio
  30. 7.5.5 Bristol-Myers Squibb Recent Developments
  31. 7.6 Aurobindo Pharma
  32. 7.6.1 Aurobindo Pharma Company Information
  33. 7.6.2 Aurobindo Pharma Business Overview
  34. 7.6.3 Aurobindo Pharma Atazanavir Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Aurobindo Pharma Atazanavir Product Portfolio
  36. 7.6.5 Aurobindo Pharma Recent Developments
8 North America
  1. 8.1 North America Atazanavir Market Size by Type
  2. 8.1.1 North America Atazanavir Revenue by Type (2021-2032)
  3. 8.1.2 North America Atazanavir Sales by Type (2021-2032)
  4. 8.1.3 North America Atazanavir Price by Type (2021-2032)
  5. 8.2 North America Atazanavir Market Size by Application
  6. 8.2.1 North America Atazanavir Revenue by Application (2021-2032)
  7. 8.2.2 North America Atazanavir Sales by Application (2021-2032)
  8. 8.2.3 North America Atazanavir Price by Application (2021-2032)
  9. 8.3 North America Atazanavir Market Size by Country
  10. 8.3.1 North America Atazanavir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Atazanavir Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Atazanavir Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Atazanavir Market Size by Type
  2. 9.1.1 Europe Atazanavir Revenue by Type (2021-2032)
  3. 9.1.2 Europe Atazanavir Sales by Type (2021-2032)
  4. 9.1.3 Europe Atazanavir Price by Type (2021-2032)
  5. 9.2 Europe Atazanavir Market Size by Application
  6. 9.2.1 Europe Atazanavir Revenue by Application (2021-2032)
  7. 9.2.2 Europe Atazanavir Sales by Application (2021-2032)
  8. 9.2.3 Europe Atazanavir Price by Application (2021-2032)
  9. 9.3 Europe Atazanavir Market Size by Country
  10. 9.3.1 Europe Atazanavir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Atazanavir Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Atazanavir Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Atazanavir Market Size by Type
  2. 10.1.1 China Atazanavir Revenue by Type (2021-2032)
  3. 10.1.2 China Atazanavir Sales by Type (2021-2032)
  4. 10.1.3 China Atazanavir Price by Type (2021-2032)
  5. 10.2 China Atazanavir Market Size by Application
  6. 10.2.1 China Atazanavir Revenue by Application (2021-2032)
  7. 10.2.2 China Atazanavir Sales by Application (2021-2032)
  8. 10.2.3 China Atazanavir Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Atazanavir Market Size by Type
  2. 11.1.1 Asia Atazanavir Revenue by Type (2021-2032)
  3. 11.1.2 Asia Atazanavir Sales by Type (2021-2032)
  4. 11.1.3 Asia Atazanavir Price by Type (2021-2032)
  5. 11.2 Asia Atazanavir Market Size by Application
  6. 11.2.1 Asia Atazanavir Revenue by Application (2021-2032)
  7. 11.2.2 Asia Atazanavir Sales by Application (2021-2032)
  8. 11.2.3 Asia Atazanavir Price by Application (2021-2032)
  9. 11.3 Asia Atazanavir Market Size by Country
  10. 11.3.1 Asia Atazanavir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Atazanavir Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Atazanavir Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Atazanavir Market Size by Type
  2. 12.1.1 SAMEA Atazanavir Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Atazanavir Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Atazanavir Price by Type (2021-2032)
  5. 12.2 SAMEA Atazanavir Market Size by Application
  6. 12.2.1 SAMEA Atazanavir Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Atazanavir Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Atazanavir Price by Application (2021-2032)
  9. 12.3 SAMEA Atazanavir Market Size by Country
  10. 12.3.1 SAMEA Atazanavir Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Atazanavir Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Atazanavir Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Atazanavir Value Chain Analysis
  2. 13.1.1 Atazanavir Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Atazanavir Production Mode & Process
  6. 13.2 Atazanavir Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Atazanavir Distributors
  9. 13.2.3 Atazanavir Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst